Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/TG Therapeutics, Inc./ 144

SEC Filing · 144

TG Therapeutics, Inc.

TGTXNASDAQEQUITYCurrent

SEC Filing

Filed Sep 10, 2026Accepted Sep 10, 2026, 4:46 PM EDTCIK 1001316Accession 0001959173-26-006866
View company →Permanent SEC source ↗
Share

Company context

Current securities

TGTXNASDAQ · EQUITY · Current

Recent company filings

  1. 10-Q filingAug 5, 2026
  2. Results of Operations and Financial ConditionAug 3, 2026
  3. 4 filingJun 15, 2026
  4. 4 filingJun 15, 2026
  5. 4 filingJun 15, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗